WebMD (WBMD) Alert: J&W Investigates Proposed Sale of WebMD Health Corp.; Is $66.50 a Fair Price?

SAN DIEGO, July 24, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP (J&W) has launched an investigation into whether the board members of WebMD Health Corp. (NASDAQ: WBMD) ("WebMD") breached their fiduciary duties in connection with the proposed sale of the Company to KKR's Internet Brands ("Internet Brands").

On July 24, 2017, WebMD announced that it had signed a definitive merger agreement with Internet Brands. Terms of the deal call for shareholders to receive $66.50 per share for each share of WebMD stock they own.

The investigation concerns whether the WebMD board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for WebMD shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration. According to Yahoo! Finance, at least one Wall Street analyst's estimated price target is $72.00 per share.

If you are a shareholder of WebMD and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471.

About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
[email protected]

SOURCE Johnson & Weaver, LLP

Related Links

http://johnsonandweaver.com